ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AXGN Axogen Inc

7,15
-0,26 (-3,51%)
18 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Axogen Inc AXGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,26 -3,51% 7,15 18:43:44
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
7,35 7,06 7,395 7,15 7,41
mais cotações »

Notícias Recentes

Data Hora Fonte Título
28/05/202417:30GLOBEAxogen Processing Center (APC) Celebrates its Opening with..
16/05/202408:00GLOBEAxogen Inc. Initiates Rolling Submission of Biologics..
14/05/202408:00GLOBEAxogen, Inc to Participate at Leerink Partners Healthcare..
02/05/202408:00GLOBEAxogen, Inc Reports First Quarter 2024 Financial Results
29/04/202417:50GLOBEAxogen Announces First Surgical Implants of Avive+ Soft..
16/04/202408:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
05/03/202409:00GLOBEAxogen, Inc Reports 2023 Fourth Quarter and Full-Year..
13/02/202418:30GLOBEAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year..
02/02/202418:15GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
18/01/202419:00GLOBEAxogen, Inc. Announces Positive Topline Results from REPOSE,..
04/01/202418:45GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
04/01/202418:40GLOBEAxogen Announces Plan for Leadership Transition with CEO..
04/01/202418:35GLOBEAxogen Announces Promotions on Research and Development Team
26/12/202318:15GLOBEAxogen, Inc. Appoints Kathy Weiler to its Board of Directors
06/12/202309:00GLOBEAxogen Announces Transition of Finance Team Leadership
01/12/202319:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20/11/202309:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
07/11/202309:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results
18/10/202308:00GLOBEAxogen, Inc. to Report Third Quarter 2023 Financial Results..
05/09/202308:00GLOBEAxogen, Inc. Announces Full Launch of Axoguard HA+ Nerve..
31/08/202308:00GLOBEAxogen to Participate at Upcoming Investor Conferences
21/08/202308:00GLOBEAxogen, Inc. Begins Processing Avance® Nerve Graft at New..
07/08/202317:01GLOBEAxogen, Inc. Reports 2023 Second Quarter Financial Results
27/07/202308:00GLOBEAxogen to Participate at Canaccord Genuity’s 43rd Annual..
26/07/202308:00GLOBEAxogen, Inc. to report second quarter 2023 financial results..